-
1 Comment
Theraclion SA is currently in a long term downtrend where the price is trading 5.7% below its 200 day moving average.
From a valuation standpoint, the stock is 93.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 16.6.
Based on the above factors, Theraclion SA gets an overall score of 1/5.
| CurrencyCode | EUR |
|---|---|
| ISIN | FR0010120402 |
| Exchange | PA |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 7M |
|---|---|
| PE Ratio | None |
| Beta | -0.14 |
| Target Price | 7 |
| Dividend Yield | None |
Theraclion SA designs and markets high-tech therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. Theraclion SA was incorporated in 2004 and is based in Malakoff, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALTHE.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
